Skip to main content

Coronavirus Infections

Molnupiravir for treating COVID-19 [NICE]

National Institute for Health and Care Excellence (NICE); 2026.

Published on 4/3/2026
Nirmatrelvir plus ritonavir and tocilizumab for treating COVID-19 [NICE]

National Institute for Health and Care Excellence (NICE); 2026.

Published on 4/3/2026
Effectiveness, Comparative Effectiveness, and Harms of COVID-19 Vaccines in Adults Who Are Not Pregnant or Immunocompromised: A Rapid Review for the American College of Physicians.

Dobrescu A. Annals of Internal Medicine 2026;:doi: 10.7326/ANNALS-25-05044.

Published on 11/3/2026
COVID-19 vaccination status during pregnancy and preeclampsia risk: the pandemic-era cohort of the INTERCOVID consortium.

Cavoretto PI. eClinicalMedicine 2026;:https://doi.org/10.1016/j.eclinm.2026.103785.

Published on 20/2/2026
Safety and immunogenicity of a single dose of Ad26.COV2.S, BNT162b2, or SARS-CoV-2-rS-protein-nanoparticle in previously vaccinated and unvaccinated adults living with and without HIV in South Africa: a phase 2a randomised, observer-blind trial.

Govender V. The Lancet HIV 2026;:https://doi.org/10.1016/S2352-3018(25)00275-9.

Published on 20/2/2026
Smartwatch-derived versus self-reported outcomes of physiological recovery after COVID-19, influenza, and group A streptococcus: a 2-year prospective cohort study.

Levi Y. The Lancet Digital Health 2026;:https://doi.org/10.1016/j.landig.2025.100956.

Published on 20/2/2026
Outpatient Treatment of Confirmed COVID-19: A Living, Rapid Review for the American College of Physicians (Version 3).

Sommer I. Annals of Internal Medicine 2026;:doi: 10.7326/ANNALS-25-03691.

Published on 11/3/2026
Menopause and Long COVID.

Royal College of Nursing (RCN); 2026.

Published on 30/1/2026
Medical oxygen and respiratory support requirements for patients hospitalised with COVID-19 in 23 low-income and middle-income countries: a prospective, observational cohort study.

Relan P. The Lancet Global Health 2026;:https://doi.org/10.1016/S2214-109X(25)00480-2.

Published on 30/1/2026
Residual lung abnormality following COVID-19 hospitalisation is characterised by biomarkers of epithelial injury.

Stewart I. eBioMedicine 2026;:https://doi.org/10.1016/j.ebiom.2026.106134.

Published on 30/1/2026

...
6
7
8
9
10
...